SCHEMBL6487657

SCHEMBL6487657

Cn1ccc2cc(CCC(=O)O)ccc21

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OXER1 Q8TDS5 2/20 0.51
S1PR1 P21453 1/20 0.48
FAAH O00519 1/20 0.47
CHRNA7 P36544 3/20 0.46
CYP2A6 P11509 1/20 0.45
PRKCI P41743 1/20 0.45
HDAC3 O15379 1/20 0.44
HDAC4 P56524 1/20 0.44
HDAC1 Q13547 1/20 0.44
HDAC7 Q8WUI4 1/20 0.44
HDAC2 Q92769 1/20 0.44
HDAC10 Q969S8 1/20 0.44
HDAC11 Q96DB2 1/20 0.44
HDAC8 Q9BY41 1/20 0.44
HDAC6 Q9UBN7 1/20 0.44
HDAC9 Q9UKV0 1/20 0.44
HDAC5 Q9UQL6 1/20 0.44
FFAR1 O14842 4/20 0.43
CYP1A2 P05177 1/20 0.43
PLA2G4A P47712 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3670301 0.88 OXER1 (0.51) OXER1FAAHCYP2A6FFAR1CYP1A2
SCHEMBL31369737 0.84 S1PR1 (0.46) OXER1S1PR1FAAHCHRNA7CYP2A6
SCHEMBL5094204 0.84 KDM4E (0.58) FAAHCHRNA7CYP2A6PRKCITRPV1
SCHEMBL28839373 0.84 CHRNA7 (0.49) FAAHCHRNA7CYP2A6HDAC3HDAC4
SCHEMBL31369499 0.81 CHRNA7 (0.52) FAAHCHRNA7CYP2A6TRPV1
SCHEMBL14402849 0.80 PRKCI (0.50) FAAHCHRNA7CYP2A6PRKCITRPV1
SCHEMBL30173446 0.79 PRKCI (0.49) FAAHCHRNA7CYP2A6PRKCITRPV1
SCHEMBL25186563 0.79 GRIK1 (0.48) OXER1FAAHCHRNA7CYP2A6PRKCI
SCHEMBL30510384 0.79 GRIK1 (0.48) OXER1FAAHCHRNA7CYP2A6PRKCI
SCHEMBL25186562 0.79 GRIK1 (0.48) OXER1FAAHCHRNA7CYP2A6PRKCI

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6972296-B2 Carboxylic acid derivatives that inhibit the binding of integrins to their receptors ENCYSIVE PHARMACEUTICALS INC. (US) 2005-12-06 US disclosed